The Kansas Institute for Precision Medicine : Zeiss Axioscan 7
The Kansas Institute for Precision Medicine : Zeiss Axioscan 7
批准号:
10610667
负责人:
ANDREW K. GODWIN
金额:
$20.97万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-01 至 2023-01-31
关键词:
AddressAdvisory CommitteesApplied ResearchAreaBasic ScienceBiomedical EngineeringBiomedical ResearchCancer CenterCaringCenters of Research ExcellenceCharacteristicsClinicClinicalCollaborationsCommunitiesCustomDepartment chairDevelopmentDiagnosisDiagnosticDietDisciplineDiseaseEnvironmentEvolutionFacultyFamilyFosteringFundingGenerationsGoalsHealthcareIndividualInfrastructureInstitutesInstitutionInternal MedicineKansasKnowledgeLaboratoriesLeadershipLife StyleMedicalMedical HistoryMedical centerMedicineMentorsMethodsMissionMolecularMolecular MedicineMolecular ProfilingOutcomeParticipantPathologyPatient CarePatient-Focused OutcomesPatientsPeer ReviewPersonsPhysiciansPrecision therapeuticsProcessProgram SustainabilityPublic HealthRecording of previous eventsResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch ProposalsResearch TrainingResource SharingRuralScienceScientistSeasonsSecureShapesTrainingTraining ProgramsTranslatingTranslational ResearchUniversitiesbasebiobankbiomarker developmentbiomarker validationclinical careclinical practicecohesioneducation researchexperiencehuman diseaseimplementation barriersimprovedindividualized medicineinnovationinsightmedical schoolsmeetingsmolecular markernext generationnovel diagnosticsorganizational structurepersonalized diagnosticspopulation healthprecision medicineprogramsrecruitstandard of caretooltranslational physiciantranslational scientist
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
The overall objective of the “Kansas Institute for Precision Medicine” (KIPM) COBRE at the University of Kansas
Medical Center (KUMC) is to advance the customization of healthcare through promoting innovative scientific
discoveries. The KIPM COBRE will provide support to advance the mission of KUMC through innovative
mentoring and training programs with a precision medicine theme. The KIPM COBRE will also strengthen the
biomedical research capacity within our region by enhancing the research base and infrastructure/core
capacities. To accomplish this, the KIPM COBRE proposes the following Specific Aims: Specific Aim 1. Recruit
and mentor a group of outstanding junior investigators in diverse disciplines with different disease focus areas
that have a common theme directed toward precision medicine. In a rigorous pre-selection process, five
promising junior investigators (and two alternative investigators) were selected from nearly 20 applicants, all of
which had a research theme directly related to precision medicine. Decisions were based on the content of
research proposals and training potential that were evaluated by our leadership team (including the three PIs of
the proposed COBRE, the senior leadership at KUMC including the Dean, department chairs, and past PIs of
COBREs within KUMC). Each applicant has been assigned at least one internal and one external mentor with
expertise related to their area of study. All COBRE faculty candidates contributed to discussions regarding
infrastructure necessary to enhance their projects via one-on-one meetings with the PIs and research core
directors were formed based in infrastructure needs to enhance their research capacity. Specific Aim 2. To
develop the scientific, technical, mentoring and collaborative infrastructure for a cohesive and sustainable
program in precision medicine. Relying on additional expertise afforded by our Internal Advisory Committee
(IAC), the External Advisory Committee (EAC), and an interactive mentoring program, we will continue to guide
and mentor the next generation of translational scientists to advance molecular medicine in the 21st century with
a thematic focus on precision medicine. Four shared resources, i.e., Administrative, Biomedical Engineering
(BME), Biobanking and Biomarker Validation (BBV), and Quantitative `Omics' (QO) Cores, will be developed to
assist the projects and serve the extended research community in Kansas and beyond. Specific Aim 3. To
foster and enhance collaborations between basic scientists and clinicians and facilitate translational research
directed toward the development of biomarkers, new diagnostics and/or treatments for human disease. Pilot
research projects funded by the School of Medicine, the Departments of Internal Medicine and Pathology and
Laboratory Medicine, and the NCI-designated KU Cancer Center, will provide opportunities to identify both senior
and junior investigators within our institute to expand the breadth and depth of research in the fields of precision
medicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
-
批准号:10526715
-
项目类别:
-
资助金额:$16.08万
-
财政年份:2021
-
负责人:ANDREW K. GODWIN
-
依托单位:
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
-
批准号:10621734
-
项目类别:
-
资助金额:$59.3万
-
财政年份:2021
-
负责人:ANDREW K. GODWIN
-
依托单位:
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
-
批准号:10373086
-
项目类别:
-
资助金额:$62.69万
-
财政年份:2021
-
负责人:ANDREW K. GODWIN
-
依托单位:
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
-
批准号:10199594
-
项目类别:
-
资助金额:$65.55万
-
财政年份:2021
-
负责人:ANDREW K. GODWIN
-
依托单位:
Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancer
-
批准号:10307656
-
项目类别:
-
资助金额:$19.59万
-
财政年份:2021
-
负责人:ANDREW K. GODWIN
-
依托单位:
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
-
批准号:10737826
-
项目类别:
-
资助金额:$15.79万
-
财政年份:2021
-
负责人:ANDREW K. GODWIN
-
依托单位:
The Kansas Institute for Precision Medicine
-
批准号:10582647
-
项目类别:
-
资助金额:$224.19万
-
财政年份:2019
-
负责人:ANDREW K. GODWIN
-
依托单位:
The Kansas Institute for Precision Medicine: IsoPlexis IsoSpark
-
批准号:10806784
-
项目类别:
-
资助金额:$16.48万
-
财政年份:2019
-
负责人:ANDREW K. GODWIN
-
依托单位:
Administrative Core
-
批准号:10867199
-
项目类别:
-
资助金额:$16.48万
-
财政年份:2019
-
负责人:ANDREW K. GODWIN
-
依托单位:
Biobanking and Biomarker Validation (BBV) Core
-
批准号:10582682
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2019
-
负责人:ANDREW K. GODWIN
-
依托单位:
Administrative Core
-
批准号:10582668
-
项目类别:
-
资助金额:$94.92万
-
财政年份:2019
-
负责人:ANDREW K. GODWIN
-
依托单位:
Administrative Core
-
批准号:10115107
-
项目类别:
-
资助金额:$49.34万
-
财政年份:2019
-
负责人:ANDREW K. GODWIN
-
依托单位:
Biobanking and Biomarker Validation (BBV) Core
-
批准号:10115115
-
项目类别:
-
资助金额:$22.21万
-
财政年份:2019
-
负责人:ANDREW K. GODWIN
-
依托单位:
Developmental Funds Core
-
批准号:10493591
-
项目类别:
-
资助金额:$68.75万
-
财政年份:2012
-
负责人:ANDREW K. GODWIN
-
依托单位:
Biospecimen Shared Resource
-
批准号:10493595
-
项目类别:
-
资助金额:$17.97万
-
财政年份:2012
-
负责人:ANDREW K. GODWIN
-
依托单位:
Biospecimen Shared Resource
-
批准号:9975733
-
项目类别:
-
资助金额:$15.19万
-
财政年份:2012
-
负责人:ANDREW K. GODWIN
-
依托单位:
Developmental Funds Core
-
批准号:10671721
-
项目类别:
-
资助金额:$66.73万
-
财政年份:2012
-
负责人:ANDREW K. GODWIN
-
依托单位:
Biospecimen Shared Resource
-
批准号:10671734
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2012
-
负责人:ANDREW K. GODWIN
-
依托单位:
Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer
-
批准号:8444503
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2010
-
负责人:ANDREW K. GODWIN
-
依托单位:
Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer
-
批准号:8730322
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2010
-
负责人:ANDREW K. GODWIN
-
依托单位:
海外基金